Download PDF
Int J Sports Med 2011; 32(12): 987-991
DOI: 10.1055/s-0031-1283186
Genetics & Molecular Biology
© Georg Thieme Verlag KG Stuttgart · New York

Is the C34T Polymorphism of the AMPD1 Gene Associated with Athlete Performance in Rowing?

P. Ciȩszczyk
1   Institute of Physical Culture, University of Szczecin, Poland
,
J. Eider
2   Faculty of Physical Culture and Health Promotion, University of Szczecin, Poland
,
M. Ostanek
3   Department of Clinical and Molecular Biochemistry, Pomeranian Medical University in Szczecin, Poland
,
A. Leońska-Duniec
4   Department of Genetics, University of Szczecin, Poland
,
K. Ficek
5   Department of Health, Galen Medical Center, Bierun, Poland
,
K. Kotarska
2   Faculty of Physical Culture and Health Promotion, University of Szczecin, Poland
,
G. Girdauskas
6   Faculty of Team Sports, Lithuanian Academy of Physical Education, Kaunas, Lithuania
› Author Affiliations
Further Information

Publication History



accepted after revision 24 May 2011

Publication Date:
21 November 2011 (online)

Also available at
    Permissions and Reprints

Abstract

The skeletal muscle-specific isoform of adenosine monophosphate deaminase (AMPD) is one of the most important regulators of muscle energy metabolism. A nonsense C to T transition in nucleotide 34 (C34T) in exon 2 of AMPD1 gene converts the codon CAA into the premature stop-codon TAA. 127 Polish male rowers including Olympic and world champions were recruited for this study. Controls samples were obtained from 251 unrelated volunteers. Statistically significant differences in genotype distribution were observed when only a whole group of rowers (88.19% CC, 11.81% CT, 0% TT; p=0.009) were compared with controls (75.31% CC, 23.10% CT, 1,59% TT). A significant deficiency of the T allele compared to control samples was noted in the elite rowers (4.55%, p=0.021) and non-elite rowers (6.63%, p=0.023), whereas this trend was even stronger when compared with the controls for the whole group of rowers (5.91%, p=0.002). Our results suggest that the T allele is associated with physical performance level, therefore, it may be included in the group of performance altering polymorphisms as a negative factor to athletic performance.

Key words

AMPD - genotype - rowing - athlete performance
 

  • References

  • 1 Ahmetov II, Williams AG, Popov DV, Lyubaeva EV, Hakimullina AM, Fedotovskaya ON, Mozhayskaya IA, Vinogradova OL, Astratenkova IV, Montgomery HE, Rogozkin VA. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet 2009; 126: 751-761
    CrossrefPubMedGoogle Scholar
  • 2 Broberg S, Sahlin K. Adenine nucleotide degradation in human skeletal muscle during prolonged exercise. J Appl Physiol 1989; 67: 116-122
    PubMedGoogle Scholar
  • 3 Cooke R, Pate E. The effects of ADP and phosphate on the contraction of muscle fibers. Biophys J 1985; 48: 789-98
    CrossrefPubMedGoogle Scholar
  • 4 De Ruiter CJ, May AM, van Engelen BG, Wevers RA, Steenbergen-Spanjers GC, de Haan A. Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects. Clin Sci 2002; 102: 531-539
    CrossrefPubMedGoogle Scholar
  • 5 Dudley GA, Staron RS, Murray TF, Hagerman FC, Luginbuhl A. Muscle fiber composition and blood ammonia levels after intense exercise in humans. J Appl Physiol 1983; 54: 582-586
    PubMedGoogle Scholar
  • 6 Eynon N, Meckel Y, Alves AJ, Nemet D, Eliakim D. Is there an interaction between BDKRB2 − 9/+9 and GNB3 C825T polymorphisms and elite athletic performance?. Scand J Med Sci Sports 2011; Jan 7 DOI: 10.1111/j.1600-0838.2010.01261.x.. [Epub ahead of print]
    PubMedGoogle Scholar
  • 7 Fishbein WN, Armbrustmacher VW, Griffin JL. Myoadenylate deaminase deficiency: a new disease of muscle. Science 1978; 200: 545-548
    CrossrefPubMedGoogle Scholar
  • 8 Fishbein WN, Foellmer JW, Davis JI. Medical implications of the lactate and ammonia relationship in anaerobic exercise. Int J Sports Med 1990; 11: 91-100
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Fischer H, Esbjornsson M, Sabina RL, Stromberg A, Peyrard-Janvid M, Norman B. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol 2007; 103: 315-322
    CrossrefPubMedGoogle Scholar
  • 10 Gross M. Molecular biology of AMP deaminase deficiency. Pharm World Sci 1994; 16: 55-61
    CrossrefPubMedGoogle Scholar
  • 11 Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis 1997; 20: 186-192
    CrossrefPubMedGoogle Scholar
  • 12 Harriss DJ, Atkinson G. Update – Ethical Standards in Sport and Exercise Science Research. Int J Sports Med 2011; 32: 819-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Lowenstein JM. The purine nucleotide cycle revised. Int J Sports Med 1990; 11: 37-46
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lucia A, Martin MA, Esteve-Lanao J, San Juan AF, Rubio JC, Oliván J, Arenas J. C34T mutation of the AMPD1 gene in an elite white runner. Br J Sports Med 2006; 40: e7
    CrossrefPubMedGoogle Scholar
  • 15 Meckel Y, Nemet D, Alves AJ, Eliakim A, Eynon N. AMPD1 C34T Mutation is not associated with the status of Israeli athletes. Eur J Sport Sci. [in press]
    PubMedGoogle Scholar
  • 16 Morisaki T, Gross M, Morisaki H, Pongratz D, Zöllner N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992; 89: 6457-6461
    CrossrefPubMedGoogle Scholar
  • 17 Morisaki T, Sabina RL, Holmes EW. Adenylate deaminase. A multigene family in humans and rats. J Biol Chem 1990; 265: 11482-11486
    PubMedGoogle Scholar
  • 18 Muniesa CA, Gonzalez-Freire M, Santiago C, Lao JI, Buxens A, Rubio JC, Martin MA, Arenas J, Gomez-Gallego F, Lucia A. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med 2008; 44: 898-901
    PubMedGoogle Scholar
  • 19 Norman B, Mahnke-Zizelman DK, Vallis A, Sabina RL. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol 1998; 85: 1273-1278
    PubMedGoogle Scholar
  • 20 Norman B, Sollevi A, Jansson E. Increased IMP content in glycogen-depleted muscle fibres during submaximal exercise in man. ActaPhysiol Scand 1988; 133: 97-100
    CrossrefPubMedGoogle Scholar
  • 21 Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study. Physiol Genomics 2003; 14: 161-166
    CrossrefPubMedGoogle Scholar
  • 22 Rubio JC, Martın MA, Rabadan M, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?. J Appl Physiol 2005; 98: 2108-2112
    CrossrefPubMedGoogle Scholar
  • 23 Rubio JC, Pérez M, Maté-Muñoz JL, García-Consuegra I, Chamorro-Viña C, Fernández del Valle M, Andreu AL, Martín MA, Arenas J, Lucia A. AMPD1 genotypes and exercise capacity in McArdle patients. Int J Sports Med 2008; 29: 331-335
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Sabina RL, Holmes EW. Myoadenylate deaminase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Vale D. (eds) The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 2001: 2627-2638
    Google Scholar
  • 25 Sabina RL, Morisaki T, Clarke P, Eddy R, Shows TB, Morton CC, Holmes EW. Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem 1990; 265: 9423-9433
    PubMedGoogle Scholar
  • 26 Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, DiMauro S, Holmes EW. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest 1984; 73: 720-730
    CrossrefPubMedGoogle Scholar
  • 27 Safronow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D. Association of C34T AMPD1 gene polymorphism with features of patients with coronary artery disease or heart failure. Scand J Clin Lab Investig 2009; 69: 102-112
    PubMedGoogle Scholar
  • 28 Safranow K, Suchy J, Jakubowska K, Olszewska M, Bińczak-Kuleta A, Kurzawski G, Rzeuski R, Czyżycka E, Łoniewska B, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases. J Appl Genetics 2011; 52: 67-76
    CrossrefPubMedGoogle Scholar
  • 29 Sahlin K, Katz A, Broberg S. Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am J Physiol Cell Physiol 1990; 259: 834-841
    PubMedGoogle Scholar
  • 30 Santiago CJ, Ruiz R, Muniesal CA, Gonzalez-Freire M, Gomez-Gallego F, Lucial A. Does the polygenic profile determine the potential for becoming a world-class athlete? Insights from the sport of rowing. Scand J Med Sci Sports 2010; 20: e188-e194
    CrossrefPubMedGoogle Scholar
  • 31 Secher NH. Physiological and biomechanical aspects of rowing. Implications for training. Sports Med 1993; 15: 24-42
    CrossrefPubMedGoogle Scholar
  • 32 Sinkeler SP, Binkhorst RA, Joosten EM, Wevers RA, Coerwinkei MM, Oei TL. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischemic isometric exercise. Clin Science 1987; 72: 475-482
    PubMedGoogle Scholar
  • 33 Spencer MK, Yan Z, Katz A. Effect of low glycogen on carbohydrate and energy metabolism in human muscle during exercise. Am J Physiol Cell Physiol 1992; 262: 975-979
    PubMedGoogle Scholar
  • 34 Tarnopolsky MA, Parise G, Gibala MJ, Graham TE, Rush JWE. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol 2001; 533: 881-889
    CrossrefPubMedGoogle Scholar
  • 35 Verzijl HT, van Engelen BG, Luyten JA, Steenbergen GC, van den Heuvel LP, ter Laak HJ, Padberg GW, Wevers RA. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol 1998; 44: 140-143
    CrossrefPubMedGoogle Scholar
  • 36 Westerblad H, Dahlstedt AJ, Lannergren J. Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibers of mouse muscle. J Physiol 1998; 510: 269-277
    CrossrefPubMedGoogle Scholar